A Randomized, Controlled Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers Using an Open Application Photoallergic Test Design
Interventional
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To determine the photoallergic (sensitizing) potential of PEP005 Gel and it's vehicle on normal skin.
6 weeks
Yes
Jonothan S Dosik, MD
Principal Investigator
TKL Research, Inc.
United States: Food and Drug Administration
PEP005-024
NCT00850681
February 2009
April 2009
Name | Location |
---|---|
TKL Research, Inc. | Paramus, New Jersey 07652 |